EDNRB inhibits the growth and migration of prostate cancer cells by activating the cGMP-PKG pathway
Prostate cancer (PCa) represents a substantial global health concern and a prominent contributor to male cancer-related mortality. The aim of this study is to explore the role of B-type endothelin receptor (EDNRB) in PCa and evaluate its therapeutic potential. The investigation employed predictive m...
Main Authors: | Li Xun, Liu Bide, Wang Shuheng, Dong Qiang, Li Jiuzhi |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2024-01-01
|
Series: | Open Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1515/med-2023-0875 |
Similar Items
-
The Role of NO/sGC/cGMP/PKG Signaling Pathway in Regulation of Platelet Function
by: Stepan Gambaryan
Published: (2022-11-01) -
Cyclic GMP and PKG Signaling in Heart Failure
by: Genri Numata, et al.
Published: (2022-04-01) -
cGMP-Dependent Protein Kinase Inhibitors in Health and Disease
by: Jens Schlossmann, et al.
Published: (2013-02-01) -
Myostatin Mutation Promotes Glycolysis by Increasing Phosphorylation of Phosphofructokinase via Activation of PDE5A-cGMP-PKG in Cattle Heart
by: Mingjuan Gu, et al.
Published: (2022-01-01) -
cGMP Signaling in Photoreceptor Degeneration
by: Shujuan Li, et al.
Published: (2023-07-01)